ReviewFrontiers in oncology2024

Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives.

Chenyang Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.